OBJECTIVES: There is a lot of variability between the results of studies reporting the pattern of gray matter volume changes in schizophrenia. Methodological issues may play an important role in this heterogeneity. The aim of the present study was to replicate the better performance of multivariate "source-based morphometry" (SBM) over the mass-univariate approach. EXPERIMENTAL DESIGN: Voxel-based morphometry of Jacobian-modulated gray matter volume images, using voxel and cluster level inference, and SBM were performed in a group of first-episode schizophrenia patients (N = 49) and healthy controls (N = 127). RESULTS: Using SBM we were able to find a significant reduction of gray matter volume in fronto-temporo-cerebellar areas whereas no significant results were obtained using voxel-based morphometry. CONCLUSION: Multivariate analysis of gray matter volume seems to be a suitable method for characterization of the pattern of changes at the beginning of the illness in schizophrenia subjects. (c) 2009 Wiley-Liss, Inc.
OBJECTIVES: There is a lot of variability between the results of studies reporting the pattern of gray matter volume changes in schizophrenia. Methodological issues may play an important role in this heterogeneity. The aim of the present study was to replicate the better performance of multivariate "source-based morphometry" (SBM) over the mass-univariate approach. EXPERIMENTAL DESIGN: Voxel-based morphometry of Jacobian-modulated gray matter volume images, using voxel and cluster level inference, and SBM were performed in a group of first-episode schizophreniapatients (N = 49) and healthy controls (N = 127). RESULTS: Using SBM we were able to find a significant reduction of gray matter volume in fronto-temporo-cerebellar areas whereas no significant results were obtained using voxel-based morphometry. CONCLUSION: Multivariate analysis of gray matter volume seems to be a suitable method for characterization of the pattern of changes at the beginning of the illness in schizophrenia subjects. (c) 2009 Wiley-Liss, Inc.
Authors: M M Haznedar; M S Buchsbaum; C Luu; E A Hazlett; B V Siegel; J Lohr; J Wu; R J Haier; W E Bunney Journal: Am J Psychiatry Date: 1997-05 Impact factor: 18.112
Authors: A Bertolino; A Breier; J H Callicott; C Adler; V S Mattay; M Shapiro; J A Frank; D Pickar; D R Weinberger Journal: Neuropsychopharmacology Date: 2000-02 Impact factor: 7.853
Authors: P G Nestor; M E Shenton; R W McCarley; J Haimson; R S Smith; B O'Donnell; M Kimble; R Kikinis; F A Jolesz Journal: Am J Psychiatry Date: 1993-12 Impact factor: 18.112
Authors: Yi-Ou Li; Fanpei G Yang; Christopher T Nguyen; Shelly R Cooper; Sara C LaHue; Sandya Venugopal; Pratik Mukherjee Journal: Hum Brain Mapp Date: 2011-05-12 Impact factor: 5.038
Authors: Amanda R Bolbecker; Jerillyn S Kent; Isaac T Petersen; Mallory J Klaunig; Jennifer K Forsyth; Josselyn M Howell; Daniel R Westfall; Brian F O'Donnell; William P Hetrick Journal: Schizophr Bull Date: 2013-08-20 Impact factor: 9.306
Authors: William D Hopkins; Robert D Latzman; Mary Catherine Mareno; Steven J Schapiro; Aida Gómez-Robles; Chet C Sherwood Journal: Cereb Cortex Date: 2019-08-14 Impact factor: 5.357
Authors: Amanda L Rodrigue; Aaron F Alexander-Bloch; Emma E M Knowles; Samuel R Mathias; Josephine Mollon; Marinka M G Koenis; Nora I Perrone-Bizzozero; Laura Almasy; Jessica A Turner; Vince D Calhoun; David C Glahn Journal: Cereb Cortex Date: 2020-07-30 Impact factor: 5.357
Authors: Emma Sprooten; Cota Navin Gupta; Emma E M Knowles; D Reese McKay; Samuel R Mathias; Joanne E Curran; Jack W Kent; Melanie A Carless; Marcio A Almeida; Thomas D Dyer; Harald H H Göring; Rene L Olvera; Peter Kochunov; Peter T Fox; Ravi Duggirala; Laura Almasy; Vince D Calhoun; John Blangero; Jessica A Turner; David C Glahn Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2015-10-05 Impact factor: 3.568
Authors: Nathan J Kolla; Carla L Harenski; Keith A Harenski; Melanie Dupuis; Jennifer J Crawford; Kent A Kiehl Journal: Neuroimage Clin Date: 2021-04-15 Impact factor: 4.881